https://doi.org/10.4081/reumatismo.2019.1102
Novel autoantibodies in rheumatoid arthritis
Submitted: 28 November 2017
Accepted: 6 September 2018
Published: 1 April 2019
Accepted: 6 September 2018
Abstract Views: 2859
PDF: 1650
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Rheumatoid factor and antibodies against cyclic citrullinated peptides represent a diagnostic hallmark in rheumatoid arthritis (RA). However, over the last decades many other autoantibodies have been identified. Several proteins can trigger an aberrant autoimmune response in their native form while others acquire this feature after post-translational modifications such as citrullination, carbamylation or acetylation. It is of interest that also the enzymes catalyzing such post-translational modifications (e.g. the protein arginine deiminases) can transform themselves into autoantibodies in RA. The purpose of this review article is to provide an overview of relevant literature published over the last years regarding novel autoantibodies and their possible diagnostic and prognostic significance in RA.
How to Cite
Bonifacio, A., Alunno, A., La Paglia, G., Valentini, E., Leone, M., Bartoloni, E., & Gerli, R. (2019). Novel autoantibodies in rheumatoid arthritis. Reumatismo, 71(1), 1–12. https://doi.org/10.4081/reumatismo.2019.1102
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo, Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review , Reumatismo: Vol. 75 No. 1 (2023)
- H. Parente, M. Pontes Ferreira, C. Soares, F. Guimarães, S. Azevedo, D. Santos-Faria, J. Tavares-Costa, D. Peixoto, C. Afonso, D. Roriz, F. Teixeira, Lumbosacral pain in a patient with psoriatic arthritis: when the rheumatic disease is innocent , Reumatismo: Vol. 75 No. 4 (2023)
- C. Sales, F. Oliviero, P. Spinella, The mediterranean diet model in inflammatory rheumatic diseases , Reumatismo: Vol. 61 No. 1 (2009)
- A. Sulli, A. Burroni, M. Tuccio, C. Pizzorni, C. Craviotto, M. Ghio, M. Basso, B. Seriolo, M. Cutolo, Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement , Reumatismo: Vol. 56 No. 1 (2004)
- M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese, Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology , Reumatismo: Vol. 76 No. 3 (2024)
- V. Riccieri, A. Spadaro, E. Taccari, A. Zoppini, I. Markus, M. Sesztak, J. Ortutay, E. Koo, Immunohistochemical analysis of the expression of main adhesion molecules and tumor necrosis factors in the synovial membrane of psoriatic arthritis , Reumatismo: Vol. 55 No. 3 (2003)
- F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano, Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study , Reumatismo: Vol. 72 No. 1 (2020)
- M.A. Cimmino, Does magnetic resonance represent the gold-standard of imaging for the follow-up of arthritis? , Reumatismo: Vol. 58 No. 4 (2006)
- F. Lioté, Treatment of hyperuricemia, gout and other crystalline arthritidies , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- G. El Hasbani, A. Jawad, I. Uthman, Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases , Reumatismo: Vol. 73 No. 1 (2021)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
You may also start an advanced similarity search for this article.
